Author(s): Guna Gouru, T.S Durga Prasad

Email(s): gouru.guna@gmail.com , tsdurgaprasad@gmail.com

DOI: 10.52711/0974-360X.2024.00416   

Address: Guna Gouru1, T.S Durga Prasad2
1Pharm. D, Sri Padmavathi School of Pharmacy, Tiruchanoor, Tirupati, Andhra Pradesh - 517503.
2Professor and Head, Department of Pharmacy Practice, Sri Padmavathi School of Pharmacy, Tiruchanoor, Tirupati, Andhra Pradesh - 517503.
*Corresponding Author

Published In:   Volume - 17,      Issue - 6,     Year - 2024


ABSTRACT:
A 34-year-old man with a 5-year history of psoriasis had applied topical clobetasol propionate ointment and presented with severe shortness of breath, severe pain all over the body, and no records of previous trauma. Physical examination showed severe psoriasis with striae all over the body, which was associated with a cushingoid appearance. MRI of the dorso-lumbar spine was performed, and the results revealed multilevel chronic compression fractures from D6 to D12 levels with mild mid-body wedgings and chronic adjacent endplate changes. Kyphosis centered at the D8 vertebra was caused by osteoporosis. The patient was diagnosed with Iatrogenic or medication-related Cushing’s syndrome caused by the long-term use of clobetasol propionate. The topical clobetasol ointment was stopped and replaced with systemic hydrocortisone and a once-a-week alendronate tablet. Iatrogenic Cushing's syndrome is most frequently caused by systemic corticosteroid misuse,when strong glucocorticoid, like clobetasol, is applied to the skin and mucosa, the same phenomenon occurs.


Cite this article:
Guna Gouru, T.S Durga Prasad. Topical Corticosteroid Induced Osteoporotic Vertebral Fractures – A Case Report. Research Journal of Pharmacy and Technology. 2024; 17(6):2658-0. doi: 10.52711/0974-360X.2024.00416

Cite(Electronic):
Guna Gouru, T.S Durga Prasad. Topical Corticosteroid Induced Osteoporotic Vertebral Fractures – A Case Report. Research Journal of Pharmacy and Technology. 2024; 17(6):2658-0. doi: 10.52711/0974-360X.2024.00416   Available on: https://rjptonline.org/AbstractView.aspx?PID=2024-17-6-35


REFERENCES:
1.    Steffano Piaserico, Dennis Linder, Francesco Messina and Mauro Alaibac.Osteoporotic vertebral fracture caused by topical corticosteroid abuse: A case report. Experimental and Therapeutic Medicine. 2019; 18: 2746-2748.doi: 10.3892/etm.2019.7825
2.    Deep Dutta, Shivaprasad KS, Sjoy Ghosh, Satinath Mukhopadhyay, Subhankar Chowdary.Iatrogenic Cushing’s Syndrome Following Short-Term Intranasal Steroid Use. J Clin Res Pediatr Endocrinol. 2014; 4(3): 157-159. doi:10.4274/jcrpe.726
3.    Maryam Razzaghy Azar, Asieh Mosalla Nejad, Ensieh Nasli Esfahani and Mona Noubakhsh.Iatrogenic Cushing’s syndrome Caused by Topical Corticosteroid Application and Its Life Threatening Complications. J. Compr. Ped. 2015; 6(4): e34336.doi:10.5812/compreped.59819
4.    Jack S. Kao, Joachim W. Fluhr, Mao-Qiang Man, Ashley J. Fowler, Jean-Pierre Hachem, Debra Crumrine, Sung K. Ahn, Barbara E. Brown, Peter M. Elias and Kenneth R. Feingoldn. Short-Term Glucocorticoid Treatment Compromises Both Permeability Barrier Homeostasis and Stratum Corneum Integrity: Inhibition of Epidermal Lipid Synthesis Accounts for Functional Abnormalities. J Invest Dermatol. 2003; 120: 456-464. doi:https://doi.org/10.1046/j.1523-1747.2003.12053.x
5.    Evange Romas.Corticosteroid-induced osteoporosis and fractures. Australian Prescriber. 2008; 31(2): 45-49. doi:10.18773/austprescr.2008.026
6.    Karen Koenig Berris, Anita Lopes Repp and Michael Kleerekoper. Glucocorticoid-induced osteoporosis. Curr Opin Endocrinol Diabetes Obes. 2007; 14: 446–450. doi:10.1097/MED.0b013e3282f15407
7.    Sultan Al-Khenaizan,Ibrahim Al Alwan.Topical steroid-induced Cushing syndrome. Ann Saudi Med. 2008; 28(4): 300-302. doi:10.5144/0256-4947.2008.300
8.    Muzeyyen Gonul and Engin Gonul.A case of multiple bone fractures due to the use of topical corticosteroid therapy for psoriasis, Journal of Dermatological Treatment. 2015; 26(3): 215-216. doi:10.3109/09546634.2014.933164
9.    Ramzan Gen, Esen Akbay, Kerem Sezer. Cushing Syndrome Caused by Topical Corticosteroid: A Case Report. Am J Med Sci. 2007; 333(3): 173–174.doi:10.1097/MAJ.0b013e3180318fbcx
10.    McGonagle DG, McInnes IB, Kirham BW, et al. The role of IL-17A in axial spondyloarthritis and psoriatic arthritis: recent advances and controversies. Ann Rheum Dis. 2019; 78:1167–1178. doi:10.1136/annrheumdis-2019-215356
11.    Hiroyuki Tsukazaki and Takashi Kaito. The Role of the IL-23/IL-17 Pathway in the Pathogenesis of Spondyloarthritis. Int. J. Mol. Sci. 2020; 21: 1-19. doi:10.3390/ijms21176401

Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

1.3
2021CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank


Recent Articles




Tags


Not Available